Barrett's esophagus (disorder)
Clinical Trial: AspECT
Year Started: 2005
AspECT: A Phase III, Randomised Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia. Trial has 10-year follow up period with samples collected throughout. Patient age groups given in the Sample Sets are the age of the patients at trial randomisation
- Access:
- Open to applicants
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- Commercial restriction, DNA restriction
Associated Data Type | Procurement Timeframe |
---|---|
Followup records | 0 - 3 months |
Pathology records | 3 - 6 months |
Physiological/biochemical measurements | 0 - 3 months |
Treatment records | 0 - 3 months |
Male
Young adult (18 - 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 51 - 75% |
Whole blood | -60°C to -85°C | N/A | Not applicable | 51 - 75% |